{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T22:05:30Z","timestamp":1789423530839,"version":"build-2803163510"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T00:00:00Z","timestamp":1748995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T00:00:00Z","timestamp":1748995200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Res"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1038\/s41390-025-04163-1","type":"journal-article","created":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T10:31:56Z","timestamp":1749033116000},"page":"1181-1183","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Vitamin C for neuroprotection in neonatal encephalopathy"],"prefix":"10.1038","volume":"98","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0788-8028","authenticated-orcid":false,"given":"Raul","family":"Chavez-Valdez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nazli","family":"Kuter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srishti","family":"Jayakumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,4]]},"reference":[{"key":"4163_CR1","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1136\/adc.49.4.278","volume":"49","author":"BP Adlard","year":"1974","unstructured":"Adlard, B. P., De Souza, S. W. & Moon, S. Ascorbic acid in fetal human brain. Arch. Dis. Child 49, 278\u2013282 (1974).","journal-title":"Arch. Dis. Child"},{"key":"4163_CR2","doi-asserted-by":"publisher","first-page":"e21477","DOI":"10.1096\/fj.202002557RR","volume":"35","author":"EJ Camm","year":"2021","unstructured":"Camm, E. J. et al. Maternal antioxidant treatment protects adult offspring against memory loss and hippocampal atrophy in a rodent model of developmental hypoxia. FASEB J. 35, e21477 (2021).","journal-title":"FASEB J."},{"key":"4163_CR3","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1017\/S0007114513000913","volume":"110","author":"JG Schjoldager","year":"2013","unstructured":"Schjoldager, J. G., Tveden-Nyborg, P. & Lykkesfeldt, J. Prolonged maternal vitamin C deficiency overrides preferential fetal ascorbate transport but does not influence perinatal survival in Guinea Pigs. Br. J. Nutr. 110, 1573\u20131579 (2013).","journal-title":"Br. J. Nutr."},{"key":"4163_CR4","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.brainres.2006.04.045","volume":"1095","author":"S Miura","year":"2006","unstructured":"Miura, S. et al. Intraventricular ascorbic acid administration decreases hypoxic-ischemic brain injury in newborn rats. Brain Res. 1095, 159\u2013166 (2006).","journal-title":"Brain Res."},{"key":"4163_CR5","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1038\/jp.2009.1","volume":"29","author":"H Aly","year":"2009","unstructured":"Aly, H. et al. Ascorbic acid combined with ibuprofen in hypoxic ischemic encephalopathy: a randomized controlled trial. J. Perinatol. 29, 438\u2013443 (2009).","journal-title":"J. Perinatol."},{"key":"4163_CR6","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1056\/NEJMcps050929","volume":"353","author":"S Shankaran","year":"2005","unstructured":"Shankaran, S. et al. Whole-body hypothermia for neonates with hypoxic-ischemic encephalopathy. N. Engl. J. Med. 353, 1574\u20131584 (2005).","journal-title":"N. Engl. J. Med."},{"key":"4163_CR7","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1056\/NEJMoa1112066","volume":"366","author":"S Shankaran","year":"2012","unstructured":"Shankaran, S. et al. Childhood outcomes after hypothermia for neonatal encephalopathy. N. Engl. J. Med. 366, 2085\u20132092 (2012).","journal-title":"N. Engl. J. Med."},{"key":"4163_CR8","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1056\/NEJMoa1315788","volume":"371","author":"D Azzopardi","year":"2014","unstructured":"Azzopardi, D. et al. Effects of hypothermia for perinatal asphyxia on childhood outcomes. N. Engl. J. Med. 371, 140\u2013149 (2014).","journal-title":"N. Engl. J. Med."},{"key":"4163_CR9","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/S0140-6736(05)17946-X","volume":"365","author":"PD Gluckman","year":"2005","unstructured":"Gluckman, P. D. et al. Selective head cooling with mild systemic hypothermia after neonatal encephalopathy: multicentre randomised trial. Lancet 365, 663\u2013670 (2005).","journal-title":"Lancet"},{"key":"4163_CR10","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/1471-2431-8-17","volume":"8","author":"D Azzopardi","year":"2008","unstructured":"Azzopardi, D. et al. The Toby Study. Whole body hypothermia for the treatment of perinatal asphyxial encephalopathy: a randomised controlled trial. BMC Pediatr. 8, 17 (2008).","journal-title":"BMC Pediatr."},{"key":"4163_CR11","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1056\/NEJMoa2119660","volume":"387","author":"YW Wu","year":"2022","unstructured":"Wu, Y. W. et al. Trial of erythropoietin for hypoxic-ischemic encephalopathy in newborns. N. Engl. J. Med. 387, 148\u2013159 (2022).","journal-title":"N. Engl. J. Med."},{"key":"4163_CR12","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1002\/jnr.23178","volume":"91","author":"N Lobo","year":"2013","unstructured":"Lobo, N., Yang, B., Rizvi, M. & Ma, D. Hypothermia and xenon: novel noble guardians in hypoxic-ischemic encephalopathy. J. Neurosci. Res. 91, 473\u2013478 (2013).","journal-title":"J. Neurosci. Res."},{"key":"4163_CR13","first-page":"CD012753","volume":"8","author":"CM Ruegger","year":"2018","unstructured":"Ruegger, C. M., Davis, P. G. & Cheong, J. L. Xenon as an adjuvant to therapeutic hypothermia in near-term and term newborns with hypoxic-ischaemic encephalopathy. Cochrane Database Syst. Rev. 8, CD012753 (2018).","journal-title":"Cochrane Database Syst. Rev."},{"key":"4163_CR14","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.ejpn.2021.02.003","volume":"31","author":"J Ahmed","year":"2021","unstructured":"Ahmed, J., Pullattayil, S. A., Robertson, N. J. & More, K. Melatonin for neuroprotection in neonatal encephalopathy: a systematic review & meta-analysis of clinical trials. Eur. J. Paediatr. Neurol. 31, 38\u201345 (2021).","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"4163_CR15","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1891\/11-T-755","volume":"40","author":"K O\u2019Mara","year":"2021","unstructured":"O\u2019Mara, K. & McPherson, C. Neuroprotective agents for neonates with hypoxic-ischemic encephalopathy. Neonatal Netw. 40, 406\u2013413 (2021).","journal-title":"Neonatal Netw."},{"key":"4163_CR16","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1001\/jama.2017.7218","volume":"318","author":"S Shankaran","year":"2017","unstructured":"Shankaran, S. et al. Effect of depth and duration of cooling on death or disability at age 18 months among neonates with hypoxic-ischemic encephalopathy: a randomized clinical trial. JAMA 318, 57\u201367 (2017).","journal-title":"JAMA"},{"key":"4163_CR17","doi-asserted-by":"crossref","unstructured":"Faix, R. G. et al. Whole-body hypothermia for neonatal encephalopathy in preterm infants 33 to 35 weeks\u2019 gestation: a randomized clinical trial. JAMA Pediatr. 179, 396-406 (2025).","DOI":"10.1001\/jamapediatrics.2025.1441"},{"key":"4163_CR18","doi-asserted-by":"publisher","first-page":"748150","DOI":"10.3389\/fneur.2021.748150","volume":"12","author":"R Chavez-Valdez","year":"2021","unstructured":"Chavez-Valdez, R. et al. Therapeutic hypothermia modulates the relationships between indicators of severity of neonatal hypoxic ischemic encephalopathy and serum biomarkers. Front. Neurol. 12, 748150 (2021).","journal-title":"Front. Neurol."},{"key":"4163_CR19","doi-asserted-by":"publisher","first-page":"114158","DOI":"10.1016\/j.jpeds.2024.114158","volume":"273","author":"H Fribance","year":"2024","unstructured":"Fribance, H. et al. Oral clonidine-based strategy to reduce opiate use during cooling for neonatal encephalopathy: an observational study. J. Pediatr. 273, 114158 (2024).","journal-title":"J. Pediatr."},{"key":"4163_CR20","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1007\/s12640-024-00719-x","volume":"42","author":"OL Adebayo","year":"2024","unstructured":"Adebayo, O. L., Agu, V. A., Idowu, G. A., Ezejiaku, B. C. & Atunnise, A. K. The role of vitamin C on ATPases activities in monosodium glutamate-induced oxidative stress in rat striatum and cerebellum. Neurotox. Res.42, 40 (2024).","journal-title":"Neurotox. Res."},{"key":"4163_CR21","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.freeradbiomed.2024.12.001","volume":"227","author":"FA Beltran","year":"2025","unstructured":"Beltran, F. A. et al. Distinct roles of ascorbic acid in extracellular vesicles and free form: implications for metabolism and oxidative stress in presymptomatic Huntington\u2019s disease. Free Radic. Biol. Med. 227, 521\u2013535 (2025).","journal-title":"Free Radic. Biol. Med."},{"key":"4163_CR22","doi-asserted-by":"crossref","unstructured":"Gunapala, K. M. et al. Ascorbic acid ameliorates molecular and developmental defects in human-induced pluripotent stem cell and cerebral organoid models of fragile X syndrome. Int. J. Mol. Sci. 25, 12718 (2024).","DOI":"10.3390\/ijms252312718"},{"key":"4163_CR23","doi-asserted-by":"crossref","unstructured":"Pilat, P., Nikel, K., Smolarczyk, J. & Piegza, M. The use of ascorbic acid in adjunctive treatment for schizophrenia-current state of knowledge. Life. 14, 828 (2024).","DOI":"10.3390\/life14070828"},{"key":"4163_CR24","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1203\/01.PDR.0000054685.87405.59","volume":"53","author":"T Ogihara","year":"2003","unstructured":"Ogihara, T. et al. Non-protein-bound transition metals and hydroxyl radical generation in cerebrospinal fluid of newborn infants with hypoxic ischemic encephalopathy. Pediatr. Res. 53, 594\u2013599 (2003).","journal-title":"Pediatr. Res."},{"key":"4163_CR25","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1016\/j.neuint.2008.01.006","volume":"52","author":"K Liu","year":"2008","unstructured":"Liu, K. et al. Comparative study of change in extracellular ascorbic acid in different brain ischemia\/reperfusion models with in vivo microdialysis combined with on-line electrochemical detection. Neurochem. Int. 52, 1247\u20131255 (2008).","journal-title":"Neurochem. Int."},{"key":"4163_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.brainres.2009.06.016","volume":"1283","author":"M Hasegawa","year":"2009","unstructured":"Hasegawa, M., Ogihara, T., Tamai, H. & Hiroi, M. Hypothermic inhibition of apoptotic pathways for combined neurotoxicity of iron and ascorbic acid in differentiated Pc12 cells: reduction of oxidative stress and maintenance of the glutathione redox state. Brain Res. 1283, 1\u201313 (2009).","journal-title":"Brain Res."},{"key":"4163_CR27","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1016\/j.freeradbiomed.2005.01.001","volume":"38","author":"M Hiroi","year":"2005","unstructured":"Hiroi, M. et al. Regulation of apoptosis by glutathione redox state in Pc12 cells exposed simultaneously to iron and ascorbic acid. Free Radic. Biol. Med. 38, 1057\u20131072 (2005).","journal-title":"Free Radic. Biol. Med."},{"key":"4163_CR28","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.neuron.2009.11.031","volume":"65","author":"MS Fanselow","year":"2010","unstructured":"Fanselow, M. S. & Dong, H. W. Are the dorsal and ventral hippocampus functionally distinct structures?. Neuron 65, 7\u201319 (2010).","journal-title":"Neuron"},{"key":"4163_CR29","doi-asserted-by":"crossref","unstructured":"St Pierre, M. et al. Unbiased quantitative single-cell morphometric analysis to identify microglia reactivity in developmental brain injury. Life. 13, 899 (2023).","DOI":"10.3390\/life13040899"},{"key":"4163_CR30","doi-asserted-by":"crossref","unstructured":"Charriaut-Marlangue, C., Besson, V. C. & Baud, O. Sexually dimorphic outcomes after neonatal stroke and hypoxia-ischemia. Int. J. Mol. Sci. 19, 61 (2017).","DOI":"10.3390\/ijms19010061"},{"key":"4163_CR31","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.neuroscience.2013.12.023","volume":"260","author":"R Chavez-Valdez","year":"2014","unstructured":"Chavez-Valdez, R., Martin, L. J., Razdan, S., Gauda, E. B. & Northington, F. J. Sexual dimorphism in Bdnf signaling after neonatal hypoxia-ischemia and treatment with necrostatin-1. Neuroscience 260, 106\u2013119 (2014).","journal-title":"Neuroscience"},{"key":"4163_CR32","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1111\/j.1750-3639.2005.tb00526.x","volume":"15","author":"MV Johnston","year":"2005","unstructured":"Johnston, M. V. Excitotoxicity in perinatal brain injury. Brain Pathol. 15, 234\u2013240 (2005).","journal-title":"Brain Pathol."},{"key":"4163_CR33","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1093\/jnen\/nlab135","volume":"81","author":"MT Panayotacopoulou","year":"2022","unstructured":"Panayotacopoulou, M. T. et al. Microglia activation in the midbrain of the human neonate: the effect of perinatal hypoxic-ischemic injury. J. Neuropathol. Exp. Neurol. 81, 208\u2013224 (2022).","journal-title":"J. Neuropathol. Exp. Neurol."}],"container-title":["Pediatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41390-025-04163-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-025-04163-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-025-04163-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T19:02:28Z","timestamp":1761246148000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41390-025-04163-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,4]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["4163"],"URL":"https:\/\/doi.org\/10.1038\/s41390-025-04163-1","relation":{},"ISSN":["0031-3998","1530-0447"],"issn-type":[{"value":"0031-3998","type":"print"},{"value":"1530-0447","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,4]]},"assertion":[{"value":"17 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}